Luigi D. Notarangelo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Luigi D. Notarangelo has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
Alberto G. Ugazio
Istituto di Medicina Molecolare “AngeloNocivelli”, Clinica Pediatrica, Università diBrescia, Brescia, Italy.2TampereUniversity Medical Hospital, Tampere, Finland.3ClinicalGene Therapy Branch, NHGRI-NIH, Bethesda, Maryland, USA
3 shared publications- Anna Villa
San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy
3 shared publications Cinzia Mazza
From the Department of Pediatrics, Istituto di Medicina Molecolare Angelo Nocivelli, University of Brescia; the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; and the Department of Pediatrics, University of Washington, Seattle
3 shared publicationsGianfranco Savoldi
3 shared publicationsPatrizia Mella
3 shared publicationsSilvia Giliani
From the Department of Pediatrics, Istituto di Medicina Molecolare Angelo Nocivelli, University of Brescia; the Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; and the Department of Pediatrics, University of Washington, Seattle
3 shared publications
Latest Publications
- Open Access
- 15 March 2002
- Published by American Society of Hematology in Blood
- Vol. 99 (6) , 2268-2269
Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia
Mutations of the WASP gene have been previously shown to be responsible for classical Wiskott-Aldrich syndrome, isolated X-linked thrombocytopenia, and severe, congenital X-linked neutropenia. We report herewith 2 families in which affected males had a history of intermittent thrombocytopenia with consistently reduced platelet volume, in the absence of other major clinical features, and carried missense mutations of the WASP gene that allowed substantial protein expression. This observation broadens the spectrum of clinical phenotypes associated with WASP gene defects, and it indicates the need for molecular analysis in males with reduced platelet volume, regardless of the platelet number.
- 15 March 2002
- Published by American Society of Hematology in Blood
- Vol. 99 (6) , 2268-2269
Open AccessMissense mutations of the WASP gene cause intermittent X-linked thrombocytopenia
Mutations of the WASP gene have been previously shown to be responsible for classical Wiskott-Aldrich syndrome, isolated X-linked thrombocytopenia, and severe, congenital X-linked neutropenia. We report herewith 2 families in which affected males had a history of intermittent thrombocytopenia with consistently reduced platelet volume, in the absence of other major clinical features, and carried missense mutations of the WASP gene that allowed substantial protein expression. This observation broadens the spectrum of clinical phenotypes associated with WASP gene defects, and it indicates the need for molecular analysis in males with reduced platelet volume, regardless of the platelet number.
- 1 October 2001
- Published by Hindawi Limited in Human Mutation
- Vol. 18 (4) , 255-263
Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency
During the last 10 years, an increasing number of genes have been identified whose abnormalities account for primary immunodeficiencies, with defects in development and/or function of the immune system. Among them is the JAK3-gene, encoding for a tyrosine kinase that is functionally coupled to cytokine receptors which share the common gamma chain. Defects of this gene cause an autosomal recessive form of severe combined immunodeficiency with almost absent T-cells and functionally defective B-cells (T(-)B(+) SCID). Herewith, we present molecular information on the first 27 unique mutations identified in the JAK3 gene, including clinical data on all of the 23 affected patients reported so far. A variety of mutations scattered throughout all seven functional domains of the protein, and with different functional effects, have been identified. Availability of a molecular screening test, based on amplification of genomic DNA, facilitates the diagnostic approach, and has permitted recognition that JAK3 deficiency may also be associated with atypical clinical and immunological features. Development of a structural model of the JAK3 kinase domain has allowed characterization of the functional effects of the various mutations. Most importantly, molecular analysis at the JAK3 locus results in improved genetic counseling, allows early prenatal diagnosis, and prompts appropriate treatment (currently based on hematopoietic stem cell transplantation) in affected families.
- 1 October 2001
- Published by Hindawi Limited in Human Mutation
- Vol. 18 (4) , 255-263
Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency
During the last 10 years, an increasing number of genes have been identified whose abnormalities account for primary immunodeficiencies, with defects in development and/or function of the immune system. Among them is the JAK3-gene, encoding for a tyrosine kinase that is functionally coupled to cytokine receptors which share the common gamma chain. Defects of this gene cause an autosomal recessive form of severe combined immunodeficiency with almost absent T-cells and functionally defective B-cells (T(-)B(+) SCID). Herewith, we present molecular information on the first 27 unique mutations identified in the JAK3 gene, including clinical data on all of the 23 affected patients reported so far. A variety of mutations scattered throughout all seven functional domains of the protein, and with different functional effects, have been identified. Availability of a molecular screening test, based on amplification of genomic DNA, facilitates the diagnostic approach, and has permitted recognition that JAK3 deficiency may also be associated with atypical clinical and immunological features. Development of a structural model of the JAK3 kinase domain has allowed characterization of the functional effects of the various mutations. Most importantly, molecular analysis at the JAK3 locus results in improved genetic counseling, allows early prenatal diagnosis, and prompts appropriate treatment (currently based on hematopoietic stem cell transplantation) in affected families.
- 1 January 2001
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 8 (1) , 41-46
Recombinase activating gene enzymes of lymphocytes
Expression of T-cell receptor and surface immunoglobulins on T and B lymphocytes, respectively, is strictly dependent on the variable, (diversity) joining exon (V(D)J) recombination process, which is initiated by the lymphoid-specific recombinase activating gene proteins 1 and 2 (RAG1 and RAG2). Recent advances have highlighted the functional organization of the RAG1 and RAG2 proteins and have provided important information on the regulation of RAG gene expression. Depending on the severity of their effects on the V(D)J recombination process, mutations of the RAG genes account for a spectrum of combined immune deficiencies in humans.
- 1 January 2001
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 8 (1) , 41-46
Recombinase activating gene enzymes of lymphocytes
Expression of T-cell receptor and surface immunoglobulins on T and B lymphocytes, respectively, is strictly dependent on the variable, (diversity) joining exon (V(D)J) recombination process, which is initiated by the lymphoid-specific recombinase activating gene proteins 1 and 2 (RAG1 and RAG2). Recent advances have highlighted the functional organization of the RAG1 and RAG2 proteins and have provided important information on the regulation of RAG gene expression. Depending on the severity of their effects on the V(D)J recombination process, mutations of the RAG genes account for a spectrum of combined immune deficiencies in humans.
- 1 December 2000
- Published by Wiley in Immunological Reviews
- Vol. 178 (1) , 39-48
Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency.Defects of the gc‐JAK3 signaling pathway as a model
Click on the article title to read more.
- 1 December 2000
- Published by Wiley in Immunological Reviews
- Vol. 178 (1) , 39-48
Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency.Defects of the gc‐JAK3 signaling pathway as a model
Click on the article title to read more.
- 1 August 2000
- Published by Elsevier in Immunobiology
- Vol. 202 (2) , 106-119
Combined Immunodeficiencies Due to Defects in Signal Transduction: Defects of the γc-JAK3 Signaling Pathway as a Model
- 1 August 2000
- Published by Elsevier in Immunobiology
- Vol. 202 (2) , 106-119
Combined Immunodeficiencies Due to Defects in Signal Transduction: Defects of the γc-JAK3 Signaling Pathway as a Model
- Open Access
- 15 November 1999
- Published by American Society of Hematology in Blood
- Vol. 94 (10) , 3468-3478
Intrathymic Restriction and Peripheral Expansion of the T-Cell Repertoire in Omenn Syndrome
Mutations in the human RAG genes that impair, but do not abolish, recombination activity lead to Omenn syndrome, a severe primary immune deficiency that is associated with clinical and pathological features of graft-versus-host disease and oligoclonal expansion of activated, autologous T cells. We have analyzed the mechanisms accounting for peripheral oligoclonality of the T-cell repertoire. Predominance of few T-cell receptor clonotypes (both within TCRAB- and within TCRGD-expressing lymphocytes) is already detectable in the thymus and is further selected for in the periphery, with a different distribution of clonotypes in different tissues. These data indicate that oligoclonality of the T-cell repertoire in Omenn syndrome is due both to intrathymic restriction and to peripheral expansion. Moreover, the RAG genes defect that causes Omenn syndrome directly affects early stages of V(D)J recombination, but does not alter the process of double-strand-break DNA repair, including N and P nucleotide insertion.
- 15 November 1999
- Published by American Society of Hematology in Blood
- Vol. 94 (10) , 3468-3478
Open AccessIntrathymic Restriction and Peripheral Expansion of the T-Cell Repertoire in Omenn Syndrome
Mutations in the human RAG genes that impair, but do not abolish, recombination activity lead to Omenn syndrome, a severe primary immune deficiency that is associated with clinical and pathological features of graft-versus-host disease and oligoclonal expansion of activated, autologous T cells. We have analyzed the mechanisms accounting for peripheral oligoclonality of the T-cell repertoire. Predominance of few T-cell receptor clonotypes (both within TCRAB- and within TCRGD-expressing lymphocytes) is already detectable in the thymus and is further selected for in the periphery, with a different distribution of clonotypes in different tissues. These data indicate that oligoclonality of the T-cell repertoire in Omenn syndrome is due both to intrathymic restriction and to peripheral expansion. Moreover, the RAG genes defect that causes Omenn syndrome directly affects early stages of V(D)J recombination, but does not alter the process of double-strand-break DNA repair, including N and P nucleotide insertion.
- 1 August 1999
- Published by Elsevier in Current Opinion in Immunology
- Vol. 11 (4) , 435-442
RAG and RAG defects
- 1 August 1999
- Published by Elsevier in Current Opinion in Immunology
- Vol. 11 (4) , 435-442
RAG and RAG defects
- 31 August 1996
- Published by Elsevier in Current Opinion in Immunology
- Vol. 8 (4) , 448-453
Immunodeficiencies caused by genetic defects in protein kinases
- 31 August 1996
- Published by Elsevier in Current Opinion in Immunology
- Vol. 8 (4) , 448-453
Immunodeficiencies caused by genetic defects in protein kinases